Maurizio Casarrubea Selected Research

(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)

1/2022	Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats.
1/2022	The effect of cannabinoid receptor agonist WIN 55,212-2 on anxiety-like behavior and locomotion in a genetic model of absence seizures in the elevated plus-maze.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maurizio Casarrubea Research Topics

Disease

4	Pain (Aches) 09/2019 - 08/2012
2	Seizures (Absence Seizure) 01/2022 - 01/2019
2	Tobacco Use Disorder (Nicotine Dependence) 04/2021 - 03/2020
1	Absence Epilepsy (Childhood Absence Epilepsy) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Brain Diseases (Brain Disorder) 01/2020
1	Epilepsy (Aura) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2019
1	Substance-Related Disorders (Drug Abuse) 01/2019
1	Tics (Tic) 01/2017

Drug/Important Bio-Agent (IBA)

2	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 01/2022 - 01/2022
2	Nicotine FDA Link 04/2021 - 03/2020
2	Morphine (MS Contin)FDA LinkGeneric 09/2019 - 08/2016
1	EndocannabinoidsIBA 01/2022
1	Cannabinoid Receptor AgonistsIBA 01/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022
1	CannabinoidsIBA 01/2022
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 01/2020
1	lorcaserinIBA 01/2020
1	Pilocarpine (Ocusert)FDA LinkGeneric 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2019
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2017
1	Pharmaceutical PreparationsIBA 08/2012
1	Diazepam (Valium)FDA LinkGeneric 08/2012

Therapy/Procedure

1	Analgesia 08/2016